Get 20% off on Global Market Reports until March 31st! Use code FY25SAVE at checkout.

How has the eye infections market grown over the years?

In recent times, the market size for eye infections has experienced robust growth. Forecasted growth from $7.53 billion in 2024 to $7.96 billion in 2025, suggests a compound annual growth rate (CAGR) of 5.7%. The historic growth can be attributed to factors such as increased exposure to environmental pollutants leading to eye irritations, a higher rate of eye infections amongst children, a surge in medical tourism for eye surgeries, demand for combined therapies for treating complex infections, and a rise in allergic conjunctivitis cases.

What Is the forecasted market size and growth rate for the eye infections market?

The market for eye infections is anticipated to witness substantial expansion in the coming years, growing to a value of $9.83 billion by 2029 while witnessing a compound annual growth rate (CAGR) of 5.4%. Factors such as the growing number of eye infection cases, an increase in the aging population susceptible to these infections, the surge in diabetes cases affecting eye health, the escalating prevalence of infections related to the use of contact lenses, and an increase in the understanding of the importance of eye health are contributing to this predicted growth. Key trends during the forecast period include advancements in diagnostic tech for identifying eye infections, AI-enabled diagnostic tools in the field, the use of 3D printing in ophthalmology, the evolution of genetically engineered treatments for rare eye conditions and the emergence of advanced antibiotics and antivirals.

Get your eye infections market report here!

https://www.thebusinessresearchcompany.com/report/eye-infections-global-market-report

What are the major factors driving growth in the eye infections market?

The eye infections market is projected to grow due to the rise in occurrences and prevalence of eye-related disorders. These disorders encompass a variety of conditions that affect the eyes which include diseases like glaucoma, cataracts, macular degeneration, and refractive errors such as myopia and hyperopia. Factors attributing to the rise in eye-related disorders include aging populations, lifestyle modifications, environmental factors, and diagnostic incompetence causing delays in detecting the problem. Eye infections can exacerbate these conditions by causing inflammation, tissue destruction, and weakening the eye’s inherent defenses, which could ultimately lead to complications like vision loss or chronic conditions. For example, data from the World Health Organization, a health authority based in Switzerland, shows that in October 2024, 130,746 individuals had surgical procedures for advanced trachoma in 2023, while 32.9 million received antibiotics, showing a global coverage of 29%. Consequently, the escalation in the occurrence and prevalence of eye-related disorders will propel the eye infections market in the future.

What key areas define the segmentation of the global eye infections Market?

The eye infections market covered in this report is segmented –

1) By Indications: Conjunctivitis, Keratitis, Endophthalmitis, Blepharitis, Stye, Uveitis, Cellulitis, Ocular Herpes

2) By Drug Type: Corticosteroids, Quinolone Antibiotics, Macrolide Antibiotics, Tetracycline Antibiotics, Polyene Antifungals

3) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies

Subsegments:

1) By Conjunctivitis: Bacterial Conjunctivitis, Viral Conjunctivitis, Allergic Conjunctivitis

2) By Keratitis: Bacterial Keratitis, Viral Keratitis, Fungal Keratitis, Acanthamoeba Keratitis

3) By Endophthalmitis: Post-surgical Endophthalmitis, Post-traumatic Endophthalmitis, Endogenous Endophthalmitis

4) By Blepharitis: Anterior Blepharitis, Posterior Blepharitis

5) By Stye: Internal Stye, External Stye

6) By Uveitis: Anterior Uveitis, Intermediate Uveitis, Posterior Uveitis, Panuveitis

7) By Cellulitis: Periorbital Cellulitis, Orbital Cellulitis

8) By Ocular Herpes: Herpes Simplex Keratitis, Herpes Simplex Conjunctivitis

Get your free sample now – explore exclusive market insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=21186&type=smp

What are the top market players propelling the growth of the eye infections industry?

Major companies operating in the eye infections market are Pfizer Inc, F. Hoffmann-La Roche AG, Merck And Co Inc, AbbVie Inc., Abbott Laboratories, Novartis AG, Takeda Pharmaceutical Company Limited, Essilor International S.A., Teva Pharmaceutical Industries Limited, Otsuka Pharmaceutical Co Ltd, Regeneron Pharmaceuticals Inc, Alcon Laboratories Inc., Bausch Health Companies Inc., Sun Pharmaceutical Industries Limited, Carl Zeiss Meditec AG, Santen Pharmaceuticals Co Ltd, Rohto Pharmaceutical Co Ltd, Topcon Corporation, Akorn Pharmaceuticals, Alembic Pharmaceuticals Limited, Novaliq GmbH, Eyevance Pharmaceuticals LLC, Ocular Therapeutix, I-Med Pharma Inc., EyeGate Pharmaceuticals Inc

What key trends are currently impacting the eye infections market’s development?

The focal point of large corporations in the eye infections market is the development of progressive therapies such as photodynamic therapy, geared towards improving treatment outcomes and minimising side-effects. Photodynamic therapy is a remedial process that utilises a light-sensitive medicine, activated by certain light wavelengths, to specifically target and obliterate abnormal or infected cells. As an example, VisiRose Inc., a clinical-stage biotech organisation based in the US, collaborated with Provectus Biopharmaceuticals Inc., an American pharmaceutical corporation, and Bascom Palmer Eye Institute, a health centre also in the US, in December 2024. They launched the Rose Bengal Photodynamic Antimicrobial Therapy (RB PDAT), a pioneering, non-intrusive research treatment for infectious keratitis and other severe eye infections. The RB PDAT offers a prospective solution to the growing global problem of antimicrobial resistance (AMR), by introducing a wide-ranging treatment for the eye. It is aimed at being safe, effective, and cost-effective, fulfilling the pressing need for novel treatments in this sector.

Unlock exclusive market insights – purchase your research report now for a swift delivery!

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=21186

What regions are dominating the eye infections market growth?

North America was the largest region in the eye infections market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the eye infections market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Browse Through More Similar Reports By The Business Research Company:

Diabetic Neuropathy Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/diabetic-neuropathy-global-market-report

Neurotechnology Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/neurotechnology-global-market-report

Automotive Glass Replacement Global Market Report 2025

https://thebusinessresearchcompany.com/report/automotive-glass-replacement-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at [email protected]

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on: